EyePoint Pharmaceuticals, Inc.

Q4 2020 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filings
35
Total reported value, excl. options
$50.7 M
Manager Report Date Value ($000) Shares Option Type